Psychedelic Clinical Trials
Find clinical trials studying psilocybin, MDMA, ketamine and other psychedelics. Many trials are actively recruiting participants who haven't found relief from conventional treatments.
Efficacy of Psilocybin in OCD: a Double-Blind, Placebo-Controlled Study.
Yale University
Psilocybin-assisted Group Therapy for Demoralization in Long-term AIDS Survivors
Joshua Woolley
Psilocybin for the Treatment of Migraine Headache
Yale University
Effects of Psilocybin in Major Depressive Disorder
Johns Hopkins University
Persisting Effects of Psilocybin
Johns Hopkins University
Psilocybin for the Treatment of Cluster Headache
Yale University
Psilocybin-facilitated Treatment for Cocaine Use
University of Alabama at Birmingham
The Effects of Psilocybin-Facilitated Experience on the Psychology and Effectiveness of Religious Professionals
NYU Langone Health
Effects of Psilocybin-facilitated Experience on the Psychology and Effectiveness of Professional Leaders in Religion
Johns Hopkins University
UW Psilocybin Pharmacokinetics Study
University of Wisconsin, Madison
A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence
NYU Langone Health
Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Johns Hopkins University
Beyond the Self and Back: Neuropharmacological Mechanisms Underlying the Dissolution of the Self
University of Zurich
Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators
Johns Hopkins University
Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence
University of New Mexico
Psilocybin and Spiritual Practice
Johns Hopkins University
Psilocybin Cancer Anxiety Study
NYU Langone Health
Psilocybin-facilitated Smoking Cessation Treatment: A Pilot Study
Johns Hopkins University
Psychopharmacology of Psilocybin in Cancer Patients
Johns Hopkins University
Effects of Psilocybin in Advanced-Stage Cancer Patients With Anxiety
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Psilocybin-Assisted Group Integration Psychotherapy for Treatment-Resistant Depression
Joshua Rosenblat
Salivary Oxytocin as a Biomarker of Psychedelic Treatment
University of Geneva, Switzerland
Phase III Long-term Extension Trial to Assess Safety and Efficacy of CYB003 in MDD (EXTEND)
Cybin IRL Limited
Psilocybin With Intracranial Neural Sensing
Joshua Woolley, MD, PhD
The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training
Felix Mueller
Psilocybin After Trauma Surgery for Pain
Trent Emerick
Psilocybin for Methamphetamine Use Disorder
Peter Hendricks
Group PACBT for Depression
University of California, Los Angeles
MLS101 Study in PMDD
MycoMedica Life Sciences PBC
Psilocybin Effects on Healthy Aging Biomarkers and Purpose in Life
Charles Raison
Psilocybin-Assisted Psychotherapy for Veterans With PTSD
ARQ National Psychotrauma Centre
NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy
M.D. Anderson Cancer Center
Pilot Study on the Effects of Psilocybin on Belief Updating and Insight Formation
Brown University
Psilocybin Therapy for Methamphetamine Use Disorder and HIV
Nicky Mehtani, MD, MPH
MB-PAT for Demoralization in Advanced Cancer ('PAT-MIND') Trial
University of Calgary
Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study
Oregon Health and Science University
Psilocybin-assisted Therapy for Post-Traumatic Stress Disorder in Survivors of Intimate Partner Violence
University of Calgary
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
National Institute on Aging (NIA)
Psilocybin-Assisted Physical Therapy in Chronic Low Back Pain
Yale University
Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids
Roswell Park Cancer Institute
Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled Trial
University Health Network, Toronto
Psilocybin for Treatment of OCD-2
Francisco A Moreno
The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.
Gabriella Gobbi
The Acute Effects of Psilocybin on Cognition, Memory, and Brain Function
Manoj Doss
Consciousness and Psilocybin Effects on Well-Being: The CoPEWell Study
University of Wisconsin, Madison
The Effects of Psilocybin on Social Connectedness
Yale University
Assessing of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies
University of New Mexico
Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder
Brigham and Women's Hospital
Browse by Condition
View all conditions →How to Join a Clinical Trial
Clinical trials are research studies that test new treatments. Participating can give you access to cutting-edge therapies while contributing to medical science. Each trial has specific eligibility criteria based on the research goals.
1. Review
Read the trial details, eligibility criteria, and what participation involves.
2. Contact
Reach out to the study team using the contact information provided.
3. Screen
Complete the screening process to determine if you're eligible.